Tocilizumab for multirefractory adult-onset Still's disease.
De Bandt
M
M
Saint-Marcoux
B
B
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology; D019947:Receptors, Interleukin-6 / Q000276:immunology*; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy* / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001323:Autoantibodies; D015850:Interleukin-6; D019947:Receptors, Interleukin-6; C502936:tocilizumab